Evidence map›Paper›PMID 15180335›Full record

ArticlePharmaceutical research2004

Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes.

Kiyomi Ito, J Brian Houston

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Environmental science & technology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Drug metabolism and disposition: the biological fate of chemicals · 2022
    Article
  6. Article
  7. Article
  8. Recent developments inDrug metabolism reviews · 2021
    Article
  9. Review
  10. Prediction of Drug Clearance from Enzyme and Transporter Kinetics.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  11. Article
  12. Using Chemical Structure Information to Develop Predictive Models forComputational toxicology (Amsterdam, Netherlands) · 2020
    Article
  13. Development and evaluation of a high throughput inhalation model for organic chemicals.Journal of exposure science & environmental epidemiology · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kiyomi ItoSchool of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester M13 9PL, UK.
J Brian Houston

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo compare three liver models (well-stirred, parallel tube, and dispersion) for the prediction of in vivo intrinsic clearance (CL(int)), hepatic clearance (CLh). and hepatic availability (Fh) of a wide range of drugs in the rat using in vitro data from two in vitro sources.

methodsIn vitro CL(int) was obtained from studies using isolated rat hepatocytes (35 drugs) or rat liver microsomes (52 drugs) and used to predict in vivo CL(int) using reported scaling factors, and subsequently CLh and Fh were predicted based on the three liver models. In addition, in vivo CL(int) values were calculated from the reported values of CLh based on each of the three models.

resultsFor all of the parameters, predictions from hepatocyte data were consistently more accurate than those from microsomal data. Comparison of in vitro and in vivo CL(int) values demonstrated that the dispersion model and the parallel tube model were comparable and more accurate (less bias, more precise) than the well-stirred model. For CLh and Fh prediction, the three models performed similarly.

conclusionsConsidering the statistics of the predictions for three liver models, the use of parallel tube model is recommended for the evaluation of in vitro CL(int) values both from microsomes and hepatocytes. However, for the prediction of the in vivo drug (hepatic) clearance from in vitro data, as there are minimal differences between the models, the use of the well-stirred liver model is recommended.

Indexed as

PharmacokineticsAlgorithmsAnimalsBiological AvailabilityCell SeparationHepatocytesHumansLiverMicrosomes, LiverModels, BiologicalPharmaceutical PreparationsPredictive Value of TestsRatsPharmaceutical Preparations

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.